Millions of Americans struggling with obesity now have access to a newly approved weight-loss drug — Zepbound — an injectable medication with the same ingredient as the diabetes drug Mounjaro, which has been shown to curb hunger cravings and help shed pounds.
The Washington Post spoke with experts and patients about how Zepbound works, how it’s different from existing diet drugs and what consumers can expect if they try it.
ncG1vNJzZmivp6x7uK3SoaCnn6Sku7G70q1lnKedZMSmuMunnKyrX2d9c3%2BOamhoaGhkxKmt02agrGWdpMKvtsCrpmaylaWvsMHNnWSwnZmctbV5y6iqrGWUp8Koew%3D%3D